NCT02595866 2024-08-09Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerNational Cancer Institute (NCI)Phase 1 Completed58 enrolled 17 charts
NCT00433485 2016-09-23Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy ParticipantsYale UniversityPhase 1 Completed16 enrolled